Nova Patents
AT304015T

Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors

Abstract

[formula (I)] 化 1 (the ring X among a formula)] The present invention is. Are a heterocyclic ring of 5*7 member and and A, Y, B, G, and W, the doria of being as having been defined as the specification -- it is related with the medicine composite and method for treating reel * オキシ * アリール * Spiro * pyrimidine *2, 4, 6* トリオン metalloproteinase inhibitor and inflammation, cancer, and other diseases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

23 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
37615702United States of AmericaP
0301576International Bureau of the World Intellectual Property Organization (WIPO)W

Members23

Family members, oldest first
DocumentOfficeKind
CA2483075A1CanadaA1
WO03091259A1World Intellectual Property Organization (WIPO)A1
AU2003219410A1AustraliaA1
AU2003219410A8AustraliaA8
UY27774A1UruguayA1
TW200306833ATaiwan Province of ChinaA
US2003225056A1United States of AmericaA1
WO03091259A8World Intellectual Property Organization (WIPO)A8
PA8572201A1PanamaA1
GT200300097AGuatemalaA
PE20040466A1PeruA1
MXPA04008563AMexicoA
EP1501834A1European Patent Office (EPO)A1
BR0309281ABrazilA
AR039661A1ArgentinaA1
US6916807B2United States of AmericaB2
EP1501834B1European Patent Office (EPO)B1
AT304015TThis recordAustriaT
ATE304015T1AustriaT1
JP2005527598AJapanA
DE60301574D1GermanyD1
DE60301574T2GermanyT2
ES2247527T3SpainT3